Purchase Order 75N91018P00274

<p>The National Cancer Institute issued a purchase order to The Broad Institute, Inc. for $13,480.01 on January 24, 2019, for custom lab work on a genomics platform. Work is performed in Cambridge, Massachusetts. The order is firm fixed-price with an ultimate completion date of July 25, 2019. No set-aside was used.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for biologicals valued at $13,401.67 on March 12, 2020, with an ultimate completion date of April 9, 2020. Place of performance is Bethesda, Maryland. The order is firm fixed price with no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC for $24,441.58 on April 24, 2018, to supply laboratory supplies. The order carries no small business set-aside. Performance occurs in Marlborough, Massachusetts. Ultimate completion is May 23, 2018. The contract uses firm fixed price terms.</p>

<p>The National Cancer Institute awarded a purchase order to Nexome Genomics Inc. for $10,000.00 on July 2, 2018. Performance occurs in Bethesda, Maryland. The order is firm fixed price with no small business set-aside. Work is scheduled for completion by August 2, 2018.</p>

<p>The National Cancer Institute awarded a purchase order to Miltenyi Biotec, Inc. for $5,631.00 on February 6, 2018, with ultimate completion on March 2, 2018. No set-aside was used. Work is performed in Bethesda, Maryland. The order is a firm fixed-price acquisition for specialized biotechnology equipment or consumables; the source does not specify the particular item or service line procured under this purchase order.</p>

<p>The National Cancer Institute awarded a purchase order to Creative Dynamics, Inc. for $10,690.00 on July 31, 2018. Work is performed in Bethesda, Maryland. The order is firm fixed price with no set-aside category applied. The ultimate completion date is July 31, 2018.</p>

<p>The National Cancer Institute awarded a purchase order to 10X Genomics, Inc. valued at $21,581.00 on August 28, 2018, with completion scheduled for September 28, 2018. Performance occurs at Bethesda, Maryland. The order is firm fixed price with no small business set-aside.</p>

<p>The National Cancer Institute awarded a purchase order to Noldus Information Technology, Inc. for $6,562.00 on March 20, 2018, with completion targeted for April 19, 2018. Performance is located in Leesburg, Virginia. The order is firm fixed price with no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to New England Biolabs, Inc. for $10,680.00 on September 5, 2018, with an ultimate completion date of October 5, 2018. Performance occurs in Bethesda, Maryland. The order is a firm fixed price purchase of molecular biology products, reagents, and research supplies. No set-aside was used.</p>

<p>The National Cancer Institute awarded a purchase order to Bioscience International Inc. for $7,415.00 on June 25, 2018, for laboratory equipment and bioscience supplies. No set-aside was used. Place of performance is North Bethesda, Maryland. The order is firm fixed price with an ultimate completion date of August 31, 2018.</p>